Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) Revenue
Annual & quarterly revenue history · segment & region breakdown
CLOV · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsClover Health Investments, Corp. trailing twelve-month (TTM) revenue is $2.21B, an increase of 40.34% year-over-year from $1.92B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.92B | +$0.55B | +40.34% |
| 2024-12-31 | $1.37B | +$0.11B | +8.77% |
| 2023-12-31 | $1.26B | +$0.16B | +14.96% |
| 2022-12-31 | $1.10B | -$0.38B | -25.51% |
| 2021-12-31 | $1.47B | +$0.80B | +118.76% |
| 2020-12-31 | $0.67B | +$0.21B | +45.56% |
| 2019-12-31 | $0.46B | +$0.18B | +64.49% |
| 2018-12-31 | $0.28B | — | — |
Compare revenue vs peers
Medical - Healthcare PlansCompare CLOV revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Clover Health Investments, Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Clover Health Investments, Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Clover Health Investments, Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CLOV revenue · 4 questionsCLOV's trailing twelve-month (TTM) revenue is $2.21B. That is an increase of 40.34% year-over-year from $1.92B in FY2025.
▸ Source: FMP · Clover Health Investments, Corp. SEC filings · GAAP · Clover Health Investments, Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026